Exactech Inc (EXAC.O)
16.23USD
10:50am EST
$-0.09 (-0.58%)
$16.32
$16.23
$16.29
$16.23
830
20,783
$19.24
$10.74
About
Overall
| Beta: | 0.62 |
| Market Cap (Mil.): | $208.92 |
| Shares Outstanding (Mil.): | 12.80 |
| Annual Dividend: | 0.00 |
| Yield (%): | NA |
Financials
| EXAC.O | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 19.25 | 4.18 | 3.76 |
| EPS (TTM): | -1.63 | -- | -- |
| ROI: | 7.51 | 2.55 | 2.30 |
| ROE: | 8.79 | 4.03 | 2.82 |
UPDATE 1-Exactech sees lower-than-expected Q2, cuts '09 rev view
July 8 (Reuters) - Exactech Inc , a maker of orthopaedic implant devices, said second-quarter results would be lower than expected and cut its 2009 revenue forecast, citing weak sales of its knee implant products.
HEADLINE STOCKS-Some U.S. stocks on the move on Feb. 19
NEW YORK, Feb 19 (Reuters) - Some U.S. stocks on the move Thursday:
UPDATE 1-Exactech raises Q1 outlook, shares rise
April 10 (Reuters) - Exactech Inc , a maker of orthopaedic implant devices, raised its first-quarter outlook on stronger worldwide sales of its core hip, knee and shoulder product lines, and sales from new distributors in Europe, sending its shares up 8 percent.
Exactech files for $100 mln stock, warrant shelf
WASHINGTON, April 2 (Reuters) - Exactech Inc on Wednesday filed with regulators to periodically sell up to $100 million in preferred and common stock and warrants.
Exactech raises 2008 revenue outlook; backs EPS view
Jan 2 (Reuters) - Exactech Inc raised its 2008 revenue outlook, but kept its earnings-per-share view unchanged.
Exactech gets subpoena from U.S.Justice Department
CHICAGO, Dec 12 (Reuters) - Exactech Inc said on Wednesday it has received a subpoena from the U.S. Department of Justice requesting documents from 1998 through the present related to consulting and professional service agreements between the company and orthopedic surgeons and other medical professionals.
Exactech to buy spinal products co. for $25 mln
Dec 10 (Reuters) - Exactech Inc , which makes orthopaedic implant devices, said it plans to exercise its investment agreement option to acquire North Carolina-based spinal products company Altiva Corp for $25 million.
Exactech Inc Q3 results
EXACTECH INC : * Third quarter revenue up 23 percent to $30.0 million; net income up 35 percent to $2.5 million or $0.21 earnings per share * Third quarter earnings per share $0.21 * Forecasts fourth quarter earnings per share $0.21 to $0.22 * Reuters Estimates third quarter earnings per share view $0.18, revenue view $28.32 million * Forecasts fiscal year 2007 earnings per share $0.78 to $0.79, excluding items * Reuters Estimates fourth quarter earnings per share view $0.21 * Reut
TABLE-Exactech Q2 net income falls
Latest Yr ago (In $) qtr EPS (diluted) 0.12 0.18 EPS, before items 0.20 0.18 Net income (million) 1.4 2.1 Net sales (million) 31.6 26.6 Reuters Estimates: EPS $0.20, revenue $29.9 million (Reporting by Supantha Mukherjee in Bangalore)
UPDATE 1-Exactech to take Q2 charge; device gets FDA approval
July 12 (Reuters) - Exactech Inc. said its second-quarter earnings would be hurt by 8 cents a share as it is anticipating delays in procuring diamond hip bearings produced by its partner Dimicron.
Competitors
| Price | Change | |
|---|---|---|
| Johnson & Johnson (JNJ.N) | $62.69 | -0.07 |
| Zimmer Holdings, Inc. (ZMH.N) | $56.87 | +0.79 |
| Stryker Corporation (SYK.N) | $51.51 | -0.40 |
| Smith & Nephew plc (SN.L) | £631.50 | -4.00 |
| Biomet, Inc. (BMET.OQ) | -- | -- |





Earnings vs
Estimates